不确定性异型增生与炎症性肠病监测中进展期肿瘤风险的相关性
该回顾性队列分析纳入492例接受结直肠肿瘤监测的结肠型炎症性肠病患者,随访2149人年,53例(10.8%)诊断为不确定性异型增生(IND)。
要点
- IND患者进展期结直肠肿瘤风险显著高于无异性增生患者(调整HR 6.85)。
- IND患者结直肠肿瘤风险亦升高(调整HR 3.25),但结肠切除术风险无显著差异。
核心结论
- 在一致性组织病理学分级下,IND与进展期结直肠肿瘤风险显著增加独立相关。
- 这些发现需验证,若被证实,需重新评估结直肠肿瘤监测指南。
研究设计与样本
- 回顾性队列分析,纳入492例结肠型IBD病程≥8年或合并原发性硬化性胆管炎、无进展期肿瘤或结肠切除术史的患者。
- 患者于2001年至2017年在三级IBD转诊中心接受结直肠肿瘤监测,并接受一致性组织病理学分级。
主要发现
- 随访2149人年后,53例(10.8%)诊断为IND,无先前或同时存在的LGD。
- 与无异性增生患者相比,IND患者进展期结直肠肿瘤风险显著升高(调整HR 6.85;95%CI 1.78-26.4)。
- 无异性增生、IND仅、LGD后进展期结直肠肿瘤发生率分别为每患者年0.4%、3.1%、8.4%。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Little is known about the clinical significance of indefinite dysplasia (IND) in patients with inflammatory bowel diseases (IBD) undergoing colonoscopic surveillance for colorectal neoplasia. METHODS: We conducted a retrospective cohort analysis of 492 patients with colonic IBD for 8 or more years or concomitant primary sclerosing cholangitis, with no history of advanced colorectal neoplasia (high-grade dysplasia or colorectal cancer) or colectomy, undergoing colorectal neoplasia surveillance at a tertiary IBD referral center from 2001 through 2017. Subjects received consistent histopathologic grading of dysplasia. We collected data on time to development of (advanced) colorectal neoplasia or colectomy using Kaplan Meier methods. We identified factors independently associated with (advanced) colorectal neoplasia with multivariable Cox regression analysis. RESULTS: After 2149 person-years of follow-up, 53 patients (10.8%) received a diagnosis of IND without prior or synchronous low-grade dysplasia (LGD). Compared to patients without dysplasia, patients with IND had a significantly higher risk of advanced colorectal neoplasia (adjusted hazard ratio, 6.85; 95% CI, 1.78-26.4) and colorectal neoplasia (adjusted hazard ratio, 3.25; 95% CI, 1.50-7.05), but not colectomy (P = .78). Compared to IND, LGD was associated with a significantly higher risk of advanced colorectal neoplasia (P = .05). Following a diagnosis of no dysplasia, IND only, or LGD, the incidence rates of advanced colorectal neoplasia were 0.4% per patient-year, 3.1% per patient-year, and 8.4% per patient-year, respectively. CONCLUSIONS: In a retrospective analysis of patients with IBD undergoing colorectal neoplasia surveillance with consistent histopathologic grading of dysplasia, IND was independently associated with a significant increase in risk of advanced colorectal neoplasia. These findings require validation and if confirmed, a reappraisal of the colorectal neoplasia surveillance guidelines.
引用
- Mahmoud R, Shah SC, Torres J, et al. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance. Clin Gastroenterol Hepatol. 2019. PMID: 31446183. doi:10.1016/j.cgh.2019.08.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。